287 related articles for article (PubMed ID: 22149217)
21. Three-dimensional poly(lactic-co-glycolic acid)/silica colloidal crystal microparticles for sustained drug release and visualized monitoring.
Guo R; Sun XT; Zhang Y; Wang DN; Yang CG; Xu ZR
J Colloid Interface Sci; 2018 Nov; 530():465-472. PubMed ID: 29990782
[TBL] [Abstract][Full Text] [Related]
22. Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer.
Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
Biomaterials; 2013 Sep; 34(27):6444-53. PubMed ID: 23755831
[TBL] [Abstract][Full Text] [Related]
23. Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.
Dhanda DS; Tyagi P; Mirvish SS; Kompella UB
J Control Release; 2013 Jun; 168(3):239-50. PubMed ID: 23562638
[TBL] [Abstract][Full Text] [Related]
24. Inhalable, large porous PLGA microparticles loaded with paclitaxel: preparation, in vitro and in vivo characterization.
Alipour S; Montaseri H; Tafaghodi M
J Microencapsul; 2015; 32(7):661-8. PubMed ID: 26415914
[TBL] [Abstract][Full Text] [Related]
25. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
[TBL] [Abstract][Full Text] [Related]
26. Controlled release of protein drugs from newly developed amphiphilic polymer-based microparticles composed of nanoparticles.
Kakizawa Y; Nishio R; Hirano T; Koshi Y; Nukiwa M; Koiwa M; Michizoe J; Ida N
J Control Release; 2010 Feb; 142(1):8-13. PubMed ID: 19804802
[TBL] [Abstract][Full Text] [Related]
27. Inhalable DNase I microparticles engineered with biologically active excipients.
Osman R; Al Jamal KT; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
Pulm Pharmacol Ther; 2013 Dec; 26(6):700-9. PubMed ID: 23933140
[TBL] [Abstract][Full Text] [Related]
28. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
Devrim B; Bozkır A; Canefe K
Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
[TBL] [Abstract][Full Text] [Related]
29. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
30. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.
Nan K; Ma F; Hou H; Freeman WR; Sailor MJ; Cheng L
Acta Biomater; 2014 Aug; 10(8):3505-12. PubMed ID: 24793657
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
32. Sustained release of a model water-soluble compound via dry powder aerosolizable acetalated dextran microparticles.
Shah NK; Wang Z; Gupta SK; Le Campion A; Meenach SA
Pharm Dev Technol; 2019 Nov; 24(9):1133-1143. PubMed ID: 31327289
[No Abstract] [Full Text] [Related]
33. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
Klose D; Delplace C; Siepmann J
Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
[TBL] [Abstract][Full Text] [Related]
34. Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion.
Yuan W; Wu F; Guo M; Jin T
Eur J Pharm Sci; 2009 Feb; 36(2-3):212-8. PubMed ID: 18832030
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics.
Tsai M; Lu Z; Wientjes MG; Au JL
J Control Release; 2013 Dec; 172(3):737-44. PubMed ID: 24056144
[TBL] [Abstract][Full Text] [Related]
36. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
37. Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications.
Wang S; Fontana F; Shahbazi MA; Santos HA
Chem Commun (Camb); 2021 Apr; 57(35):4212-4229. PubMed ID: 33913978
[TBL] [Abstract][Full Text] [Related]
38. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
39. Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery.
Cocks E; Alpar O; Somavarapu S; Greenleaf D
Drug Dev Ind Pharm; 2015 Mar; 41(3):522-8. PubMed ID: 24650006
[TBL] [Abstract][Full Text] [Related]
40. Drug release from a pH-sensitive multiblock co-polymer thermogel.
Garripelli VK; Namgung R; Kim WJ; Jo S
J Biomater Sci Polym Ed; 2012; 23(12):1505-19. PubMed ID: 21771392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]